# Dabigatran Etexilate

NDC: 46708-635
Generic name: Dabigatran Etexilate
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20240813

FDA application: ANDA215233

## Active ingredients

- DABIGATRAN ETEXILATE MESYLATE: 110 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-635"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-635
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13649035-a498-4e31-a7ea-8b18cedceca7